Woodline Partners »

Tscan Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $541k 109k 4.98
2024-06-30 $956k 164k 5.85
2022-09-30 $203k 67k 3.05
2022-06-30 $416k 132k 3.14
2022-03-31 $383k 137k 2.80
2021-12-31 $450k 100k 4.50